| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
10-27-2020, 10:43 AM
|
#1 | |||
|
||||
|
Senior Member
|
Autologous hematopoietic stem-cell transplant (AHSCT) has been around a while as a treatment for MS. The National MS Society has come out with recommendations about it.
From JAMA (October 26, 2020), there is this article, "Autologous hematopoietic stem-cell transplant in multiple sclerosis: Recommendations of the National Multiple Sclerosis Society": Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society | Stem Cell Transplantation | JAMA Neurology | JAMA Network
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| (From National MS Society) Coronavirus resources for people with MS | Multiple Sclerosis | |||
| (National MS Society) What you need to know about the Coronavirus | Multiple Sclerosis | |||
| What Triggers MS...research news from National MS Society | Multiple Sclerosis | |||
AHSCT recommendations for MS treatment from National MS Society
Linear Mode
